Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001069530-22-000009
Filing Date
2022-02-03
Accepted
2022-02-03 17:13:47
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form5.html 5  
1 PRIMARY DOCUMENT certent-form5.xml 5 4009
  Complete submission text file 0001069530-22-000009.txt   5501
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7801 N. CAPITAL OF TX HWY SUITE 260 AUSTIN TX 78731
Business Address
Schoen Eric (Reporting) CIK: 0001532303 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-29959 | Film No.: 22589645